Skip to main content
. 2023 Dec 5;30(1):271–278. doi: 10.1038/s41591-023-02696-8

Fig. 1. Patient disposition.

Fig. 1

Patient disposition for all 29 patients that were enrolled and received divarasib plus cetuximab.